Biểu đồ giá cổ phiếu UNCY
UNCY Cổ tức
Unicycive Therapeutics Inc
$5.73
8.52%
$0.45
Khi đóng cửa: Jul 02, 16:00:00 GMT-4
$5.7
-0.52%
$-0.03
Phiên sau giờ: Jul 02, 20:00:00 GMT-4
Quay lại
Unicycive Therapeutics Inc (UNCY) Cổ tức
Thống kê chính
Giá đóng cửa trước
$5.28
Giá mở cửa
$5.3
Phạm vi ngày
$5.1 - $5.79
Phạm vi 52 tuần
$3.71 - $8.74
Khối lượng
2.9M
Khối lượng trung bình
582.6K
Tỷ suất cổ tức
--
EPS (TTM)
-2.77
Vốn hóa thị trường
$152.1M
UNCY là gì?
Unicycive Therapeutics, Inc. is a biotechnology company, which engages in developing novel treatments for kidney diseases. The company is headquartered in Los Altos, California and currently employs 21 full-time employees. The company went IPO on 2021-06-17. The firm's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.
